XOMA Royalty 관리

관리 기준 확인 1/4

XOMA Royalty CEO는 Owen Hughes, Jan2023 에 임명되었습니다 의 임기는 1.83 년입니다. 총 연간 보상은 $ 2.48M, 5% 로 구성됩니다. 5% 급여 및 95% 보너스(회사 주식 및 옵션 포함). 는 € 1.04M 가치에 해당하는 회사 주식의 0.3% 직접 소유합니다. 1.04M. 경영진과 이사회의 평균 재임 기간은 각각 1.8 년과 5.8 년입니다.

주요 정보

Owen Hughes

최고 경영자

US$2.5m

총 보상

CEO 급여 비율	5.0%
CEO 임기	1.8yrs
CEO 소유권	0.3%
경영진 평균 재임 기간	1.8yrs
이사회 평균 재임 기간	5.8yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Owen Hughes 의 보수는 XOMA Royalty 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Sep 30 2024	n/a	n/a	-US$35m
Jun 30 2024	n/a	n/a	-US$24m
Mar 31 2024	n/a	n/a	-US$42m
Dec 31 2023	US$2m	US$125k	-US$46m

보상 대 시장: Owen 의 총 보상 ($USD 2.48M )은 German 시장( $USD 995.28K ).

보상과 수익: Owen 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.

CEO

Owen Hughes (49 yo)

1.8yrs

테뉴어

US$2,482,735

보상

Mr. Owen P. Hughes, Jr. serves as Chief Executive Officer of XOMA Royalty Corporation (formerly known as XOMA Corporation) from January 2024 and serves as its Director since January 01, 2023 and served as...

리더십 팀

이름	위치	테뉴어	보상	소유권
Owen Hughes	CEO & Director	1.8yrs	US$2.48m	0.30% € 1.0m
Thomas Burns	Senior VP of Finance & CFO	9.6yrs	US$2.27m	0.12% € 430.8k
Brad Sitko	Chief Investment Officer	1.8yrs	US$8.56m	0.060% € 210.2k

1.8yrs

평균 재임 기간

49yo

평균 연령

경험이 풍부한 관리: X0M1 의 관리팀은 경험 (평균 재직 기간 1.8 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Owen Hughes	CEO & Director	1.8yrs	US$2.48m	0.30% € 1.0m
Jack Wyszomierski	Independent Chairman	14.3yrs	US$232.53k	0.055% € 191.3k
Joseph Limber	Independent Director	11.9yrs	US$210.04k	0.053% € 183.8k
Matthew Perry	Independent Director	7.8yrs	US$197.54k	0.10% € 349.2k
Barbara Kosacz	Independent Director	5.8yrs	US$196.04k	0% € 0
Heather Franklin	Independent Director	3.3yrs	US$203.95k	0% € 0
Natasha Hernday	Independent Director	4.3yrs	US$207.64k	0% € 0

5.8yrs

평균 재임 기간

58yo

평균 연령

경험이 풍부한 이사회: X0M1 의 이사회는 경험(평균 재직 기간 5.8 년)으로 간주됩니다.

XOMA Royalty 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Insufficient new directors

XOMA Corporation, Annual General Meeting, May 15, 2024

Xoma Appoints Jack L. Wyszomierski as Chairman of the Board of Directors

XOMA Corporation Appoints Owen Hughes as Interim Chief Executive Officer

XOMA Corporation, Annual General Meeting, May 18, 2022

CEO & Director recently sold €254k worth of stock

Recent updates

Third quarter 2024 earnings released: US$1.59 loss per share (vs US$0.60 loss in 3Q 2023)

Insufficient new directors

New minor risk - Shareholder dilution

Second quarter 2024 earnings released: EPS: US$1.37 (vs US$0.59 loss in 2Q 2023)

First quarter 2024 earnings released: US$0.86 loss per share (vs US$0.98 loss in 1Q 2023)

XOMA Corporation (NasdaqGM:XOMA) completed the acquisition of Kinnate Biopharma Inc. (NasdaqGS:KNTE).

XOMA Corporation, Annual General Meeting, May 15, 2024

XOMA Corporation (NasdaqGM:XOMA) entered into a definitive merger agreement to acquire Kinnate Biopharma Inc. (NasdaqGS:KNTE) for approximately $120 million.

XOMA Corporation (NasdaqGM:XOMA) entered into a definitive merger agreement to acquire Kinnate Biopharma Inc. (NasdaqGS:KNTE) for approximately $120 million.

Xoma Appoints Jack L. Wyszomierski as Chairman of the Board of Directors

XOMA Corporation (NasdaqGM:XOMA) announces an Equity Buyback for $50 million worth of its shares.

New minor risk - Profitability

Third quarter 2023 earnings released: US$0.60 loss per share (vs US$0.48 loss in 3Q 2022)

New major risk - Revenue and earnings growth

Second quarter 2023 earnings released: US$0.59 loss per share (vs US$0.53 loss in 2Q 2022)

First quarter 2023 earnings released: US$0.98 loss per share (vs US$0.32 loss in 1Q 2022)

Full year 2022 earnings released: US$1.50 loss per share (vs US$0.69 profit in FY 2021)

Investor sentiment improved over the past week

XOMA Corporation Appoints Owen Hughes as Interim Chief Executive Officer

Investor sentiment improved over the past week

Third quarter 2022 earnings released: US$0.48 loss per share (vs US$0.51 loss in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: US$0.53 loss per share (vs US$0.31 loss in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

XOMA Corporation(NasdaqGM:XOMA) dropped from Russell 2000 Dynamic Index

First quarter 2022 earnings released: US$0.32 loss per share (vs US$0.70 loss in 1Q 2021)

Investor sentiment deteriorated over the past week

XOMA Corporation, Annual General Meeting, May 18, 2022

Now 22% undervalued

Investor sentiment improved over the past week

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Third quarter 2021 earnings released: US$0.51 loss per share (vs US$0.098 loss in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: US$0.31 loss per share (vs US$0.33 loss in 2Q 2020)

CEO & Director recently sold €254k worth of stock

First quarter 2021 earnings released: US$0.70 loss per share (vs US$0.49 loss in 1Q 2020)

Full year 2020 earnings released: EPS US$0.82 (vs US$0.23 loss in FY 2019)

Revenue beats expectations

New 90-day high: €29.32

XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement

Revenue misses expectations

Third quarter 2020 earnings released: US$0.098 loss per share

New 90-day high: €20.84

XOMA Corporation Earns $25 Million Milestone Payment

XOMA Corporation announced that it has received $1.4 million in funding from Rezolute, Inc.

New 90-day high: €17.92

XOMA Corporation to Report Q2, 2020 Results on Aug 06, 2020

Earnings released

New 90-day low - €14.03

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령